Transplantation: Clinical Trials

54 trials for Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 10 unknown, 9 recruiting, 2 terminated. 18 Not applicable, 9 Phase 4, 7 Phase 3, 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable18Completed 9, Recruiting 6, Unknown 2, Terminated 1
Phase 49Completed 4, Unknown 3, Terminated 1, Withdrawn 1
Phase 37Completed 5, Unknown 2
Phase 24Completed 2, Not yet recruiting 1, Recruiting 1
Phase 12Completed 1, Recruiting 1

Follow Transplantation: new trials by email Literature Review of Transplantation trials Research Report on Transplantation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial
Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells, Placebo - Spinal Cord Injury, Safety
Phase 2Not yet recruitingXellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.602028-05-252025-11-25
In-situ vs Ex-situ Liver Preservation
In-situ perfusion: aNRP, Ex-situ perfusion: DHOPE/DHOPE-COR-NMP - Liver Disease (Alcoholic or Not), Transplantation
Not applicableRecruitingLeiden University Medical Center7522026-11-042026-11-03
Effect of Breathing Exercise on Pain and Quality of Recovery in After Transplantation Patients: A Randomized Controlled Trial
respiratory exercise - Transplantation, Pain Management
Not applicableRecruitingAnkara Yildirim Beyazıt University602025-08-012025-12-15
Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial
Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells - Spinal Cord Injury, Safety
Phase 1RecruitingXellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.122025-07-022025-11-25
Clinical Study of Venetoclax Combined With Azacitidine as Bridging Therapy Prior to Hematopoietic Stem Cell Transplantation in Patients With Higher-Risk Myelodysplastic Syndromes
VEN (Venetoclax) - Myelodysplastic Neoplasms, Transplantation
Phase 2RecruitingYehui Tan462025-07-012025-08-08
Digital Delivery of Person-centered Transitional Care
Stepstones transition program - Asthma in Children, Transplantation
Not applicableRecruitingGöteborg University1002024-10-012026-09-15
Extended Validation of Donor-derived Cell-free DNA in Kidney Transplant Recipients
Donor-derived cell-free DNA - Rejection Acute Renal, Rejection Chronic Renal
Active not recruitingParis Translational Research Center for Organ Transplantation50002024-06-152026-09-04
Psychological Impact of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation on Donors
Evaluate the evolution of the psychic state of the donors (ascendants and descendants), by means of questionnaires, within the framework of haplo-identical allograft. - Haplo-identical Transplantation, Transplantation
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris502024-01-222025-04-02
Transplant Wellness Program
Transplant Wellness Program - Kidney and Liver - Transplantation
Not applicableRecruitingUniversity of Calgary4202023-11-162026-04-29
Effect of Intraoperative Music on Inflammatory Response in Donor Hepatectomy
music, no music - Transplantation, Hepatectomy
Not applicableCompletedIstinye University612023-05-222025-09-22
Observational Study on the Variation of Ascorbic Acid in Patients Undergoing Solid Organ Transplantation
Transplantation, Ascorbic Acid Deficiency
UnknownPoliclinico Hospital402023-02-012024-09-04
Specific Genotypes/Phenotypes of Pneumocystis Jirovecii in Solid Organ Transplant Recipients: Potential Involvement of Mycophenolic Acid
Transplantation, Pulmonary Diseases
CompletedUniversity Hospital, Brest1002022-07-042025-04-13
Qualitative and Quantitative Evaluation of Vascular Flows of Radial, Ulnar and Interdigital Arterial Trees Under Normal and Pathological Conditions by 3 Tesla MRI
MRI acquisitions, Doppler ultrasound procedure - Magnetic Resonance Imaging, Vascular Complications
Not applicableRecruitingCentre Hospitalier Universitaire, Amiens462021-09-012025-06-10
PD-1 Inhibitor Tislelizumab Maintenance Therapy in Newly Diagnosed DLBCL Patients After ASCT
PD-1 Inhibitor Tislelizumab maintenance therapy - Lymphoma, Large B-Cell, Diffuse, Transplantation
Phase 3UnknownRuijin Hospital942021-07-092021-11-22
Transplantation of Vaginal Mikrobiome
Vaginal Microbiome Transplant, Vaginal Microbiome Transplant Placebo, No intervention - Vaginal Dysbiosis, Vaginal Microbiome
Not applicableCompletedCopenhagen University Hospital, Hvidovre3022021-06-012023-03-27
PD-1 Inhibitor Tislelizumab Maintenance Therapy in R/R DLBCL Patients After ASCT
PD-1 Inhibitor Tislelizumab maintenance therapy - Lymphoma, Large B-Cell, Diffuse, Transplantation
Phase 3UnknownRuijin Hospital1322021-04-012021-03-16
Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation
Transplant patient - Transplantation
CompletedUniversity Hospital, Bordeaux36022020-05-112021-06-07
Benefits of Exercise Program in Pediatric HSCT
Exercise program - Exercise, Transplantation
Not applicableCompletedPhoenix Children's Hospital402019-03-112022-02-01
Precision Medicine Offers Belatacept Monotherapy
Belatacept - Transplantation
Phase 4WithdrawnUniversity of California, San Francisco2019-02-012022-12-06
mHealth Family Self-Management
myFAMI - Transplantation, Pediatric ALL
Not applicableCompletedMedical College of Wisconsin672018-10-012020-07-09

Showing 20 of 54. Sign in to see all of them.

Narrower conditions

Kidney Failure, Chronic (4)  ·  Critical Illness (2)  ·  Infections (2)  ·  Liver Diseases (2)  ·  Lymphoma, Large B-Cell, Diffuse (2)  ·  Motor Activity (2)  ·  Renal Insufficiency (2)  ·  Spinal Cord Injuries (2)  ·  Agnosia (1)  ·  Anxiety Disorders (1)  ·  Ascorbic Acid Deficiency (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  COVID-19 (1)  ·  Chronic Disease (1)  ·  Cytomegalovirus Infections (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (10)  ·  Pathologic Processes (9)  ·  Immune System Diseases (8)  ·  Urogenital Diseases (8)  ·  Disease Attributes (7)  ·  Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Kidney Diseases (6)  ·  Male Urogenital Diseases (6)  ·  Respiratory Tract Diseases (6)  ·  Urologic Diseases (6)  ·  Hemic and Lymphatic Diseases (5)  ·  Virus Diseases (5)  ·  Behavior (4)  ·  Cardiovascular Diseases (4)

Interventions

Tacrolimus (6)  ·  Sirolimus (4)  ·  Cyclosporine (3)  ·  Abatacept (2)  ·  Azacitidine (1)  ·  Breathing Exercises (1)  ·  Chorionic Villi Sampling (1)  ·  Daclizumab (1)  ·  Hand Transplantation (1)  ·  Influenza Vaccines (1)  ·  Interleukin-2 (1)  ·  Liver Extracts (1)  ·  Music Therapy (1)  ·  Mycophenolic Acid (1)  ·  Pantoprazole (1)

Sponsors

Astellas Pharma Inc (3)  ·  Hospices Civils de Lyon (2)  ·  National Taiwan University Hospital (2)  ·  Ruijin Hospital (2)  ·  University Hospital, Bordeaux (2)  ·  University of Pittsburgh (2)  ·  XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. (2)  ·  Ankara Yildirim Beyazıt University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bristol-Myers Squibb (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Copenhagen University Hospital, Hvidovre (1)  ·  Emory University (1)  ·  Federal University of São Paulo (1)

Countries

France (16)  ·  United States (11)  ·  China (7)  ·  Germany (7)  ·  Spain (6)  ·  Sweden (6)  ·  United Kingdom (5)  ·  Belgium (4)  ·  Italy (4)  ·  Poland (4)  ·  Netherlands (3)  ·  Switzerland (3)  ·  Turkey (Türkiye) (3)  ·  Austria (2)  ·  Brazil (2)

Top investigators

Limin Rong, prof and M.D (2)  ·  Alberto Sanchez-Fueyo (1)  ·  Alexander Ngwube, MD (1)  ·  Ali Sait Kavakli, M.D. (1)  ·  Beyza Zeynep Kocabicak (1)  ·  Chul-Woo Jung, MD. PhD (1)  ·  Claus P Schmitt, MD (1)  ·  David L Paterson, MD (1)  ·  Deepali Kumar, MD (1)  ·  Emmanuel Morelon, Pr (1)  ·  Eolia Brissot (1)  ·  Flavio Vincenti, MD (1)

Results publications

PMID 10221490, PMID 10798738, PMID 12438948, PMID 12761269, PMID 15660173, PMID 15899725, PMID 19670189, PMID 21040167, PMID 21564530, PMID 22211928, PMID 23137211, PMID 24011252, PMID 25136843, PMID 25293374, PMID 25583616, PMID 26463883, PMID 28963316, PMID 30172032, PMID 31352795, PMID 32385825, PMID 33230714, PMID 34233458, PMID 35185912, PMID 35195344, PMID 35838761, PMID 35977080, PMID 36087863, PMID 36927114, PMID 37498313, PMID 37833387, PMID 39449962, PMID 41905375, PMID 42419896

NIH funding

2004 (1), 2008 (1)